Danielle Petersel

Publications8
h-index7
Citations441
Highly Influential Citations34
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • A. Baranauskaitė
  • 39 Publications, 1,167 Citations
  • I. Jacobs
  • 50 Publications, 1,078 Citations
  • S. J. Lee
  • 46 Publications, 2,015 Citations
  • W. Park
  • 87 Publications, 740 Citations
  • Publications
  • Influence
A patient survey of the impact of fibromyalgia and the journey to diagnosis
BackgroundFibromyalgia is a painful, debilitating illness with a prevalence of 0.5-5.0% that affects women more than men. It has been shown that the diagnosis of fibromyalgia is associated with… Expand
  • 156
  • 11
Survey of physician experiences and perceptions about the diagnosis and treatment of fibromyalgia
BackgroundFibromyalgia (FM) is a condition characterized by widespread pain and is estimated to affect 0.5-5% of the general population. Historically, it has been classified as a rheumatologic… Expand
  • 62
  • 7
Central amplification and fibromyalgia: Disorder of pain processing
Fibromyalgia (FM), a complex chronic pain disorder affecting a heterogeneous patient population, is an area of active basic and clinical research. Although diagnostic criteria for FM have been… Expand
  • 61
  • 5
The Language of Biosimilars: Clarification, Definitions, and Regulatory Aspects
Biologic therapies have revolutionized treatment of a number of diseases. Patents and exclusivity for a number of biologics are expiring. This has created the opportunity for the development and… Expand
  • 60
  • 4
Biosimilar Drugs for Psoriasis: Principles, Present, and Near Future
Psoriasis is a chronic, inflammatory, lifelong disease with a high prevalence (afflicting approximately 1–5% of the population worldwide) and is associated with significant morbidity. The… Expand
  • 27
  • 3
Monoclonal Antibody and Fusion Protein Biosimilars Across Therapeutic Areas: A Systematic Review of Published Evidence
BackgroundDespite regulatory efforts to formalize guidance policies on biosimilars, there remains a need to educate healthcare stakeholders on the acknowledged definition of biosimilarity and the… Expand
  • 33
  • 2
  • PDF
Biosimilars for the Treatment of Chronic Inflammatory Diseases: A Systematic Review of Published Evidence
BackgroundClinicians are required to assimilate, critically evaluate, and extrapolate information to support appropriate use of biosimilars across indications.ObjectivesThe objective of this study… Expand
  • 37
  • 2
  • PDF
Pregabalin in Treatment-Refractory Fibromyalgia
Context: Fibromyalgia is a chronic musculoskeletal pain disorder. The pain can be intractable and may not respond to commonly-used treatments, such as tricyclic antidepressants and opioids.… Expand
  • 5
  • PDF